Cancer Medicine Price Cap: Government Approves 30% Trade Margin Limit
The cancer medicine price cap approved by the Government of India on October 8, 2026, aims to make treatment more affordable by limiting trade margins on non-scheduled anti-cancer medicines to 30% of their maximum retail price (MRP). The government estimates that the measure could save patients ₹2,500 crore annually, although the final list of medicines
Read the full report on Businesspress, Indias Most Loved Business News Por
Story file
- Section
- Health
- Topics
- Health alerts
- First reported by
- Businesspress, Indias Most Loved Business News Por
- Reporter
- startuptimes
- Published
- Friday, 9 October 2026, 9:08 am IST
- Coverage
- One outlet so far
How this page works. The Headline Update lists this report from Businesspress, Indias Most Loved Business News Por with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.
